Ziresovir
Catalog No. A20179
Ziresovir (AK0529;RO-0529) is a potent, selective, and orally bioavailable respiratory syncytial virus (RSV) fusion (F) protein (RSV F) protein inhibitor.
Catalog Num | A20179 |
---|---|
M. Wt | 439.53 |
Formula | C22H25N5O3S |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 1422500-60-4 |
Synonyms | AK0529, AK 0529, AK-0529; RO-0529, RO 0529, RO0529 |
SMILES | NC1(COC1)CNC2=NC(N(CC3)CC4=CC=CC=C4S3(=O)=O)=NC5=C2C=C(C)C=C5 |
Ziresovir (AK0529;RO-0529) is a potent, selective, and orally bioavailable respiratory syncytial virus (RSV) fusion (F) protein (RSV F) protein inhibitor.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 22.75 mL | 113.76 mL | 227.52 mL |
0.5 mM | 4.55 mL | 22.75 mL | 45.5 mL |
1 mM | 2.28 mL | 11.38 mL | 22.75 mL |
5 mM | 0.46 mL | 2.28 mL | 4.55 mL |
*The above data is based on the productmolecular weight 439.53. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.